impe0096p91 | GH and IGFs | IMPE2023
Horikawa Reiko
, Pietropoli Alberto
Objective: To evaluate the long-term safety and effectiveness of daily growth hormone (Norditropin®; somatropin) in Japanese children with short stature due to Noonan syndrome (NS).Methods: This post-marketing, prospective, non-interventional, Japanese multicentre study (NCT03435627) was conducted in a real-world setting from February 2018 to April 2022. Among the 70 enrolled patients, 35 received Norditropin® on...